Evidence
Adv Sci (Weinh). 2024 Jun 20:e2400929. doi: 10.1002/advs.202400929. Online ahead of print.
ABSTRACT
To elucidate the brain-wide information interactions that vary and contribute to individual differences in schizophrenia (SCZ), an information-resolved method is employed to construct individual synergistic and redundant interaction matrices based on regional pairwise BOLD time-series from 538 SCZ and 540 normal controls (NC). This analysis reveals a stable pattern of regionally-specific synergy dysfunction in SCZ. Furthermore, a hierarchical Bayesian model is applied to deconstruct the patterns of whole-brain synergy dysfunction into three latent factors that explain symptom heterogeneity in SCZ. Factor 1 exhibits a significant positive correlation with Positive and Negative Syndrome Scale (PANSS) positive scores, while factor 3 demonstrates significant negative correlations with PANSS negative and general scores. By integrating the neuroimaging data with normative gene expression information, this study identifies that each of these three factors corresponded to a subset of the SCZ risk gene set. Finally, by combining data from NeuroSynth and open molecular imaging sources, along with a spatially heterogeneous mean-field model, this study delineates three SCZ synergy factors corresponding to distinct symptom profiles and implicating unique cognitive, neurodynamic, and neurobiological mechanisms.
PMID:38900070 | DOI:10.1002/advs.202400929
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Mapping Brain Synergy Dysfunction in Schizophrenia: Understanding Individual Differences and Underlying Molecular Mechanisms
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Progress in The Research of Lactate Metabolism Disruption And Astrocyte-Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review
- Involvement of the TRPV1 receptor and the Endocannabinoid System in Schizophrenia
- Genetically Informed Study Highlights Income-Independent Effect of Schizophrenia Liability on Mental and Physical Health
- Impact of traumatic brain injury on risk for schizophrenia and bipolar disorder
- Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study
- Polygenic Resilience Scores are Associated with Lower Penetrance of Schizophrenia Risk Genes, Protection Against Psychiatric and Medical Disorders, and Enhanced Mental Well-Being and Cognition
- Sex differences in prevalence and clinical correlates of internet addiction among Chinese adolescents with schizophrenia
- Brain structural alterations associated with impulsiveness in male violent patients with schizophrenia
- A preliminary metabolomics study of the database for biological samples of schizophrenia among Chinese ethnic minorities
- "RNSP (Rannasangpei)" Rescued MK-801-induced Schizophrenia-like Behaviors in Mice via Oxidative Stress and BDNF-TrkB/Akt Pathway
- Discriminative analysis of schizophrenia and major depressive disorder using fNIRS
- Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders
- Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders
- Shared Genetic Determinants of Schizophrenia and Autism Spectrum Disorder Implicate Opposite Risk Patterns: A Genome-Wide Analysis of Common Variants
- SDDSynergy: Learning Important Molecular Substructures for Explainable Anticancer Drug Synergy Prediction
- A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning
- Unraveling NEK4 as a Potential Drug Target in Schizophrenia and Bipolar I Disorder: A Proteomic and Genomic Approach
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
- The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients
- Integrative ceRNA network analysis identifies unique and shared molecular signatures in Bipolar Disorder and Schizophrenia
- Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonance imaging study
- Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression
- Association of major depression, schizophrenia and bipolar disorder with thyroid cancer: a bidirectional two-sample mendelian randomized study
- Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysis
- Meta-analysis of epigenetic aging in schizophrenia reveals multifaceted relationships with age, sex, illness duration, and polygenic risk
- Cerebellar dysconnectivity in schizophrenia and bipolar disorder is associated with cognitive and clinical variables
- Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- Auditory Cortex Thickness Is Associated With N100 Amplitude in Schizophrenia Spectrum Disorders
- Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia
- A Functional Schizophrenia-associated genetic variant near the TSNARE1 and ADGRB1 genes
- Assessing regional intracortical myelination in schizophrenia spectrum and bipolar disorders using the optimized T1w/T2w-ratio
- Genetic contribution to microglial activation in schizophrenia
- Relationships between Sleep Quality, Introspective Accuracy, and Confidence Differ among People with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder with Psychotic Features
- Effort-cost decision-making associated with negative symptoms in schizophrenia and bipolar disorder
- Dysregulated Transcript Expression but Not Function of the Glutamate Transporter EAAT2 in the Dorsolateral Prefrontal Cortex in Schizophrenia
- Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter Hyperintensity
- Parvalbumin interneuron cell-to-network plasticity: mechanisms and therapeutic avenues
- Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space Index
- Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space Index
- Shared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis
- Shared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis
- Prevalence of metabolic syndrome and its associated factors in first-treatment drug-naive schizophrenia patients: A large-scale cross-sectional study
- Whole-exome sequencing in a Chinese sample provides preliminary evidence for the link between rare/low-frequency immune-related variants and early-onset schizophrenia
- Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank
- Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank
- Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study
- Integrated platform for multiscale molecular imaging and phenotyping of the human brain
- Integrated platform for multiscale molecular imaging and phenotyping of the human brain
- The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: results from the EU-GEI study
- Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity
- Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
- Body mass index, smoking behavior, and depression mediated the effects of schizophrenia on chronic obstructive pulmonary disease: trans-ethnic Mendelian-randomization analysis
- Body mass index, smoking behavior, and depression mediated the effects of schizophrenia on chronic obstructive pulmonary disease: trans-ethnic Mendelian-randomization analysis
- Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations
- Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations
- Increased whole-brain functional heterogeneity in psychosis during rest and task
- Neuroadaptive Bayesian optimisation to study individual differences in infants' engagement with social cues
- Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset
- Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset
- Quantitative Expression of Latent Disease Factors in Individuals Associated with Psychopathology Dimensions and Treatment Response
- Normative modelling of molecular-based functional circuits captures clinical heterogeneity transdiagnostically in psychiatric patients
- Photoacoustic Tomography with Temporal Encoding Reconstruction (PATTERN) for cross-modal individual analysis of the whole brain
Evidence Blueprint
Mapping Brain Synergy Dysfunction in Schizophrenia: Understanding Individual Differences and Underlying Molecular Mechanisms
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Mapping Brain Synergy Dysfunction in Schizophrenia: Understanding Individual Differences and Underlying Molecular Mechanisms
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Progress in The Research of Lactate Metabolism Disruption And Astrocyte-Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review
- Based on neural network cascade abnormal texture information dissemination of classification of patients with schizophrenia and depression
- Disease-specific resting-state EEG network variations in schizophrenia revealed by the contrastive machine learning
- Changes in patterns of age-related network connectivity are associated with risk for schizophrenia
- Involvement of the TRPV1 receptor and the Endocannabinoid System in Schizophrenia
- Schizophrenia endothelial cells exhibit higher permeability and altered angiogenesis patterns in patient-derived organoids
- Deep Learning-based Brain Age Prediction in Patients With Schizophrenia Spectrum Disorders
- In vivo mapping of protein-protein interactions of schizophrenia risk factors generates an interconnected disease network
- Genetically Informed Study Highlights Income-Independent Effect of Schizophrenia Liability on Mental and Physical Health
- Family-based genetic analysis in schizophrenia by whole-exome sequence to identify rare pathogenic variants
- Aripiprazole combined with nerve growth factor improves cognitive function in mice with schizophrenia model
- The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants
- Identification of Immune-Linked Hub Genes and Diagnostic Model Construction in Schizophrenia
- Regional cerebral blood flow at rest in schizophrenia and major depressive disorder: A functional neuroimaging meta-analysis
- Impact of traumatic brain injury on risk for schizophrenia and bipolar disorder
- Epigenetic analysis suggests aberrant cerebellum brain aging in old-aged adults with autism spectrum disorder and schizophrenia
- Longitudinal transcriptomic analysis of human cortical spheroids identifies axonal dysregulation in the prenatal brain as a mediator of genetic risk for schizophrenia
- Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study
- Polygenic Resilience Scores are Associated with Lower Penetrance of Schizophrenia Risk Genes, Protection Against Psychiatric and Medical Disorders, and Enhanced Mental Well-Being and Cognition
- Radix Bupleuri aqueous extract attenuates MK801-induced schizophrenia-like symptoms in mice: Participation of intestinal flora
- Sex differences in prevalence and clinical correlates of internet addiction among Chinese adolescents with schizophrenia
- A higher dysregulation burden of brain DNA methylation in female patients implicated in the sex bias of Schizophrenia
- Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia
- Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity
- Brain structural alterations associated with impulsiveness in male violent patients with schizophrenia
- Autophagy-related gene model as a novel risk factor for schizophrenia
- Polygenic effects on brain functional endophenotype for deficit and non-deficit schizophrenia
- A preliminary metabolomics study of the database for biological samples of schizophrenia among Chinese ethnic minorities
- EXPRESS: The relationship of the methylation status and polymorphism of glucocorticoid receptor gene (NR3C1) with attempted suicide or non-suicidal self-injury patients in schizophrenia
- "RNSP (Rannasangpei)" Rescued MK-801-induced Schizophrenia-like Behaviors in Mice via Oxidative Stress and BDNF-TrkB/Akt Pathway
- Discriminative analysis of schizophrenia and major depressive disorder using fNIRS
- A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium
- Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders
- Resting-state EEG dynamic functional connectivity distinguishes non-psychotic major depression, psychotic major depression and schizophrenia
- Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders
- Levels of neuronal pentraxin 2 in plasma is associated with cognitive function in patients with schizophrenia
- Shared Genetic Determinants of Schizophrenia and Autism Spectrum Disorder Implicate Opposite Risk Patterns: A Genome-Wide Analysis of Common Variants
- Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
- Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids
- Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids
- SDDSynergy: Learning Important Molecular Substructures for Explainable Anticancer Drug Synergy Prediction
- A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning
- Multisensory integration deficits in Schizophrenia and Autism evidenced in behaviour but not event related potentials
- Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis
- Resting-state fMRI is associated with trauma experiences, mood and psychosis in Afro-descendants with bipolar disorder and schizophrenia
- Unraveling NEK4 as a Potential Drug Target in Schizophrenia and Bipolar I Disorder: A Proteomic and Genomic Approach
- Dynamic functional connectivity in schizophrenia and bipolar disorder: A review of the evidence and associations with psychopathological features
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
- The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients
- Ribosomal DNA Copy Number Variation is Coupled with DNA Methylation Changes at the 45S rDNA Locus
- Integrative ceRNA network analysis identifies unique and shared molecular signatures in Bipolar Disorder and Schizophrenia
- Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study
- Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study
- Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonance imaging study
- Association between urban upbringing and functional brain connectivity in schizophrenia
- Multi-loss Disentangled Generative-Discriminative Learning for Multimodal Representation in Schizophrenia
- Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression
- Association of major depression, schizophrenia and bipolar disorder with thyroid cancer: a bidirectional two-sample mendelian randomized study
- MicroRNA137-loaded lipid nanoparticles regulate synaptic proteins in the prefrontal cortex
- Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysis
- Identifying risk loci for obsessive-compulsive disorder and shared genetic component with schizophrenia: A large-scale multi-trait association analysis with summary statistics
- Meta-analysis of epigenetic aging in schizophrenia reveals multifaceted relationships with age, sex, illness duration, and polygenic risk
- Immune dysregulation is associated with symptom dimensions and cognitive deficits in schizophrenia: accessible evidence from complete blood count